Top compounds associated with response to HCST


Feature Type Standardized
Nominal ANOVA
mRNA dacarbazine CTRPv2 pan-cancer AAC 0.095 0.005
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.006
mRNA Crizotinib gCSI pan-cancer AAC -0.19 0.006
mRNA nelarabine CTRPv2 pan-cancer AAC -0.11 0.006
mRNA TPCA-1 CTRPv2 pan-cancer AAC 0.094 0.007
mRNA LY-2183240 CTRPv2 pan-cancer AAC 0.091 0.007
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.007
mRNA BRD-K02251932 CTRPv2 pan-cancer AAC -0.11 0.008
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.096 0.01
mRNA thapsigargin GDSC1000 pan-cancer AAC -0.12 0.01
Download CSV